Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Long-Term Deferred Tax (2016 - 2018)

Firefly Neuroscience has reported Long-Term Deferred Tax over the past 3 years, most recently at $2.0 million for Q4 2018.

  • Quarterly results put Long-Term Deferred Tax at $2.0 million for Q4 2018, changed N/A from a year ago — trailing twelve months through Dec 2018 was $2.0 million (changed N/A YoY), and the annual figure for FY2018 was $2.0 million, changed.
  • Long-Term Deferred Tax for Q4 2018 was $2.0 million at Firefly Neuroscience, down from $6.0 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for AIFF hit a ceiling of $6.0 million in Q4 2016 and a floor of $2.0 million in Q4 2018.
  • Median Long-Term Deferred Tax over the past 3 years was $5.9 million (2015), compared with a mean of $4.7 million.
  • Peak annual rise in Long-Term Deferred Tax hit 2.63% in 2016, while the deepest fall reached 2.63% in 2016.
  • Firefly Neuroscience's Long-Term Deferred Tax stood at $5.9 million in 2015, then grew by 2.63% to $6.0 million in 2016, then plummeted by 66.12% to $2.0 million in 2018.
  • The last three reported values for Long-Term Deferred Tax were $2.0 million (Q4 2018), $6.0 million (Q4 2016), and $5.9 million (Q4 2015) per Business Quant data.